K101160

Substantially Equivalent

ROCHE ORAL FLUID COCAINE

Applicant: Roche Diagnostics
Product code: DIO
Advisory panel: Clinical Toxicology
Date received: 2010-04-26
Decision date: 2011-02-11
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Indianapolis, IN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.